SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-10-049716
Filing Date
2010-09-24
Accepted
2010-09-23 17:39:47
Documents
6
Period of Report
2010-09-23
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K a10-18206_38k.htm 8-K 23283
2 EX-1.1 a10-18206_3ex1d1.htm EX-1.1 385225
3 EX-12.1 a10-18206_3ex12d1.htm EX-12.1 48818
4 EX-25.1 a10-18206_3ex25d1.htm EX-25.1 35375
5 GRAPHIC g182063km05i001.gif GRAPHIC 138137
6 GRAPHIC g182063km03i001.gif GRAPHIC 87409
  Complete submission text file 0001104659-10-049716.txt   805172
Mailing Address
Business Address 130 WAVERLY STREET CAMBRIDGE MA 02139-4242 6165776000
VERTEX PHARMACEUTICALS INC / MA (Filer) CIK: 0000875320 (see all company filings)

IRS No.: 043039129 | State of Incorp.: MA | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-19319 | Film No.: 101087398
SIC: 2834 Pharmaceutical Preparations